Business Wire

Celgene Corporation Announces Initial Clinical Data from Ongoing Phase 1/2 Evolve Trial with Anti-BCMA CAR T Therapy JCARH125 in Relapsed/Refractory Multiple Myeloma at ASH 2018

Jaa

Celgene Corporation (NASDAQ:CELG) today announced initial safety data from its ongoing proof-of-concept trial of JCARH125 in patients with relapsed/refractory multiple myeloma. JCARH125 is an investigational BCMA-targeting CAR T cell therapy being developed by Juno Therapeutics, A Celgene Company. Results were presented by Sham Mailankody, MBBS, in an oral presentation at the 60th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, CA (Abstract #957).

The data reported from the multicenter, phase 1/2 EVOLVE trial includes patients who have been treated with JCARH125 in the dose escalation study. The primary objectives of the phase 1 portion of the trial are safety and identification of a recommended phase 2 dose. The patients enrolled in the study had to have received at least three prior lines of multiple myeloma therapy, including an autologous stem cell transplant for transplant eligible patients, a proteasome inhibitor, an immunomodulatory drug, and an anti-CD38 monoclonal antibody. Dose escalation is currently ongoing.

“We believe that cellular therapies targeting BCMA will play an important role in the future treatment of patients with multiple myeloma,” said Mark Gilbert, M.D., Chief Medical Officer for Juno Therapeutics, A Celgene Company. “These data from 44 patients in the EVOLVE trial further support our commitment to innovation in multiple myeloma clinical research.”

At data cut off, 44 patients have been infused with JCARH125 in three dose escalation cohorts. These patients were heavily pretreated, with a median of seven prior lines of therapies (range, 3-23), and 77% had high-risk cytogenetics. Seventy-one percent of patients experienced grade 1 and 2 cytokine release syndrome (CRS) with 9% of patients experiencing grade 3/4 CRS. In addition, 18% of patients experienced grade 1 and 2 neurological events with 7% of patients experiencing a grade 3/4 event. Other frequent grade 3/4 AEs included neutropenia (86%), anemia (50%), thrombocytopenia (43%) and infection (14%).

In this first report of JCARH125 data, the median follow up was only 11 weeks, yet among infused patients, the overall response rate (ORR) was 82%. At the lowest dose level of 50x106 CAR T cells, the ORR was 79% and 43% of patients achieved stringent complete response (sCR) or complete response (CR).

JCARH125 is investigational and has not been approved in any country.

About Celgene

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. For more information, please visit www.celgene.com.

Follow Celgene on Social Media: Twitter, Pinterest, LinkedIn, Facebook and YouTube.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements, which are generally statements that are not historical facts. Forward-looking statements can be identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans," "will," "outlook" and similar expressions. Forward-looking statements are based on management's current plans, estimates, assumptions and projections, and speak only as of the date they are made. Celgene undertakes no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in Celgene's Annual Report on Form 10-K and other reports filed with the Securities and Exchange Commission.

Hyperlinks are provided as a convenience and for informational purposes only. Celgene bears no responsibility for the security or content of external websites.

Contact information

Celgene Corporation
Investors:
+1-908-673-9628
ir@celgene.com
or
Media:
+1-908-673-2275
media@celgene.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Andersen Name Premieres in Kuwait27.6.2019 16:30:00 EESTTiedote

Andersen Global announced today one of the premier accounting firms in Kuwait will debut the Andersen name there, furthering the presence of Andersen Global in the Middle East. Causeway Company For Financial Management Consulting W.L.L. in Kuwait will now become Andersen Tax in Kuwait. The firm joined Andersen Global as a collaborating firm last year and will now become a full member firm of the international association. Andersen Tax in Kuwait will continue providing accounting and corporate secretarial services to individuals and corporations in a wide range of industries. “We have a shared dedication toward meeting the needs of our clients, and since becoming a collaborating firm, we gained an appreciation for the way the professionals at the member and collaborating firms of Andersen Global are growing together as an organization. We understand the impact of working with like-minded individuals around the globe with whom we share a commitment to providing seamless service internati

MobileIron Research Reveals 8 in 10 IT Leaders Want to Eliminate Passwords and Expect Mobile Devices to Become Primary Authentication to the Enterprise27.6.2019 15:00:00 EESTTiedote

MobileIron (NASDAQ:MOBL) today revealed the results of a survey conducted with IDG, which found that enterprise users and security professionals alike are frustrated by the inefficiency and lax security of passwords for user authentication. With 90% of security professionals reporting to have seen unauthorized access attempts as a result of stolen credentials, it’s clear that the future of security requires a next generation of authentication that’s more secure. Mobile devices are the best option for replacing passwords, as they remain at the center of enterprises in terms of where business is done, how access is given, and how authentication is done. In fact, the survey revealed that almost nine-in-ten (88%) security leaders believe that mobile devices will soon serve as digital ID to access enterprise services and data. The survey, sponsored by MobileIron, polled 200 IT security leaders in the US, UK, Australia, and New Zealand working in a range of industries at companies with at le

U.S. Food and Drug Administration Supports Principles of Open Sharing of Data27.6.2019 15:00:00 EESTTiedote

The U.S. Food and Drug Administration (FDA), an agency within the Department of Health and Human Services, supports the principle of openly sharing data through efforts like the Patient Safety Movement Foundation’s Open Data Pledge. Creating a healthcare system that embraces data liquidity will help empower patients to actively engage in the development and evaluation of medical devices, enable medical device surveillance to help identify and prevent adverse events from occurring, and enrich the understanding of the benefits and risks of technology utilization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190627005244/en/ FDA Letter of Support for Open Data Sharing By signing the Patient Safety Movement’s Open Data Pledge, leaders in the healthcare technology industry commit to openly sharing non-proprietary data output from their devices and systems without interference or cost. When the data is pulled together into algor

Moody’s and Team8 Launch Joint Venture to Create a Global Cyber Risk Standard27.6.2019 14:00:00 EESTTiedote

Moody’s Corporation (NYSE:MCO) and Team8, a leading cybersecurity think tank and company creation platform, announced today that they have formed a joint venture to establish a global standard for evaluating and assessing cyber risk for enterprises. The joint venture will build on Moody’s experience in developing methodologies and global standards to measure risk, together with Team8’s expertise in cybersecurity technologies, unique access to cyber talent and distinctive understanding of the global cyber threat landscape. This combined expertise will focus on the development of innovative methods and technologies that effectively measure and analyze cyber risks facing global corporations. This will include serving the needs of Boards of Directors, Audit Committees, Chief Executives, Risk and Security Officers for objective cyber risk assessment to better understand companies’ own cyber posture and how it benchmarks against others and over time. The cyber risk service will also assess t

GSMA Announces Winners of 2019 Asia Mobile Awards27.6.2019 14:00:00 EESTTiedote

The GSMA has announced the winners of the 2019 Asia Mobile Awards (AMO Awards), which were presented at the AMO Awards Ceremony and Networking Reception at MWC19 Shanghai. The awards honour the key achievements and innovations driving the mobile industry across the Asia Pacific region. “We congratulate all of the winners and nominees of the Asia Mobile Awards here at MWC19 Shanghai,” said John Hoffman, CEO, GSMA Ltd. “The AMO Awards recognise the most innovative mobile technologies, products and services, while showcasing the positive impact of mobile on individuals, business and society across the Asia Pacific region. We thank all of our entrants, judges and partners for supporting the 2019 Asia Mobile Awards.” The winners of the 2019 Asia Mobile Awards are: Best Mobile Technology Breakthrough in Asia SK Telecom for Innovative Roaming Technology 'baro'. Best IoT Innovation for Mobile Networks in Asia Telstra Corporation Limited, Ericsson for world’s first implementation of a nation-wi

TMD Security Announces Global Agreement to Integrate Easthouse’s Key-less Locks for ATM Top Box and Safe into its TMD Access Management Solution27.6.2019 14:00:00 EESTTiedote

TMD Security announced today that Nanjing Easthouse Electrical Co. Ltd (SecuRam), leading manufacturer of high-security certified locks, will be the hardware partner for TMD’s multi-vendor Access Management solution for ATM top box and safe locks. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190627005376/en/ TMD Security has integrated Easthouse’s key-less high-security locks for ATM top box and safe into TMD Access Management, a solution which works for any brand and model of ATM. This is the first single access scheduling and provision solution for ATMs and a wide variety of other access points such as secure room and branch, that uses encrypted one-time-codes and mobile app instead of physical keys. The Access Management solution is currently exclusively available through TMD Security. ‘We are proud to be integrating Easthouse’s ATM top box and safe locks into our ‘game-changing’ Access Management solution,’ said Cees H

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme